Evidence map›Paper›PMID 33589752›Full record

Trial reportLeukemia2021

Improving the identification of frail elderly newly diagnosed multiple myeloma patients.

Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein, Gert-Jan Timmers, Mels Hoogendoorn, Paula F Ypma, Inger S Nijhof, Gerjo A Velders, Leonie Strobbe, Nazik Durdu-Rayman and 19 more

Registry-linked trialAbstract readClinical Trial, Phase IIMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06099912 (Individualized Dynamic Frailty-tailored Therapy), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06099912 recruitingnot on this map

Individualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With Newly Diagnosed Multiple Myeloma: a Prospective and Multi-center Study

TypeobservationalSponsorFengYan JinRan2021 to 2029Enrolled131ConditionsMultiple Myeloma, Frailty
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Claudia A M Stege *Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. c.stege@amsterdamumc.nl.ORCID http://orcid.org/0000-0001-7476-0609
Kazem Nasserinejad *Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Saskia K KleinDepartment of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands.
Gert-Jan TimmersDepartment of Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands.
Mels HoogendoornDepartment of Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
Paula F YpmaDepartment of Hematology, Haga Hospital, The Hague, the Netherlands.
Inger S NijhofDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Gerjo A VeldersDepartment of Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, the Netherlands.ORCID http://orcid.org/0000-0002-7475-9402
Leonie StrobbeDepartment of Internal Medicine, Gelre Hospital, Zutphen, the Netherlands.
Nazik Durdu-RaymanDepartment of Internal Medicine-Hematology, Franciscus Hospital location Vlietland, Schiedam, the Netherlands.
Matthijs WestermanDepartment of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands.
Marjan A Davidis-van SchoonhovenDepartment of Internal Medicine, Beatrix Hospital, Gorinchem, the Netherlands.
Roel J W van KampenDepartment of Internal Medicine/Hematology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
Aart BeekerDepartment of Internal Medicine, MBA Spaarne Gasthuis, Hoofddorp, the Netherlands.
Ad KosterDepartment of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.
Amanda C DijkDepartment of Internal Medicine, St Jansdal Hospital, Harderwijk, the Netherlands.
Niels W C J van de DonkDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Ellen van der SpekDepartment of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands.
Rineke B L LeysDepartment of Hematology and Oncology, Maasstad Ziekenhuis, Rotterdam, the Netherlands.
Matthijs H SilbermannDepartment of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands.
Kaz GroenDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Nicole C H P van der Burg-de GraauwDepartment of Internal Medicine, Bravis ziekenhuis, Roosendaal, the Netherlands.
Harm A M SinnigeDepartment of Internal Medicine, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands.
Klaas G van der HemDepartment of Internal Medicine, Zaans Medical Center, Zaandam, the Netherlands.
Henriette LevengaDepartment of Internal Medicine, Groene Hart Hospital, Gouda, the Netherlands.
Yavuz M BilginDepartment of Internal Medicine, Admiraal de Ruijter Hospital, Goes, the Netherlands.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Mark-David LevinDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.ORCID http://orcid.org/0000-0003-2139-3547
Sonja ZweegmanDepartment of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesGeriatric AssessmentHumansMultiple MyelomaPrognosisProspective StudiesSurvival Rate

Identifiers

PMID33589752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.